v3.26.1
Accrued expenses and other current liabilities (Tables)
 6 Months Ended
Jun. 30, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Accrued Expenses and Other Current Liabilities
Accrued expenses and other current liabilities consist of the following:

(in thousands)June 30, 2026December 31, 2025
Accrued R&D costs
$24,615 $18,904 
Accrued payroll and benefits
6,019 13,257 
Accrued restructuring costs2,674 2,159 
Deferred royalty obligation, short-term21,085 11,054 
Gross-to-net sales adjustments, short-term 8,451 9,020 
Other
4,547 3,594 
$67,391 $57,988